Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer (Q44610247)
Jump to navigation
Jump to search
scientific article published in November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer |
scientific article published in November 2003 |
Statements
1 reference
Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer (English)
1 reference
1 reference
Franco Di Silverio
1 reference
1 November 2003
1 reference
1 reference
170
1 reference
5
1 reference
1812-1816
1 reference
Identifiers
1 reference
1 reference